INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

18,921 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
DK
Davis KristaSVP, CHIEF HR OFFICER
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$135K
1,730 sh
Feb 20, 2026Feb 23, 2026
Page 330 of 474
← PrevNext →
traded Feb 20, 2026
+3d
SEC Form 4

Evidence

4
DK
Davis KristaSVP, CHIEF HR OFFICER
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$162K
2,084 sh
Feb 19, 2026Feb 23, 2026
traded Feb 19, 2026
+4dSEC Form 4

Evidence

42
RW
Rogers James WilliamChief Financial Officer
TEMTempus AI, Inc.
Open-market sale
SELL$595K
10.1K sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

35
FR
Fukushima RyanChief Executive Officer, Data
TEMTempus AI, Inc.
Open-market sale
SELL$566K
9,592 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

33
CE
Cho EstherSVP, General Counsel
KROSKeros Therapeutics, Inc.
Open-market sale
SELL$78K
4,745 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

33
LR
Lerner Lorena RaquelChief Science Officer
KROSKeros Therapeutics, Inc.
Open-market sale
SELL$63K
3,873 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

31
TJ
Tasker Anthony JamesSVP & COO
FUNCFIRST UNITED CORP/MD/
Open-market sale
SELL$33.11
1 sh
Feb 4, 2026Feb 20, 2026
traded Feb 4, 2026
+16dSEC Form 4

Evidence

29
CG
Casella Matthew G.Former officer
RRRICHTECH ROBOTICS INC.
Open-market sale
SELL$34K
12.5K sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

28
CG
Campbell Darrell GeorgeEVP - CFO
SNDRSchneider National, Inc.
Open-market sale
SELL$173K
6,000 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

28
GS
Griffis SarahChief Technology Officer
MAPSWM TECHNOLOGY, INC.
Open-market sale
SELL$183K
271.0K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

28
WR
Webb Michael ReedSVP & Chief Admin Officer
ROGROGERS CORP
Open-market sale
SELL$127K
1,197 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

26
PE
Phelps ErikEVP, Chief Admin. Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$334K
5,650 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

25
TN
Townsend Richard NolanDirector, Chief Executive Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$65K
10.2K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

23
PA
Polovin AndrewEVP, Chief Legal Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$481K
8,143 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

23
PA
Polovin AndrewEVP, Chief Legal Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$654K
10.8K sh
Feb 20, 2026Feb 20, 2026
traded Feb 20, 2026
+0dSEC Form 4

Evidence

22
BL
Binz Joseph LeoChief Financial Officer
TEAMAtlassian Corp
Open-market sale
SELL$56K
698 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

22
BL
Binz Joseph LeoChief Financial Officer
TEAMAtlassian Corp
Open-market sale
SELL$58K
711 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

22
OM
Otero Jose ManuelChief Operating Officer
LXEOLexeo Therapeutics, Inc.
Open-market sale
SELL$19K
3,016 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

21
AR
Artis Dean RichardEVP & CHIEF SCIENTIFIC OFFICER
ANNXAnnexon, Inc.
Open-market sale
SELL$27K
5,290 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

19
BL
Binz Joseph LeoChief Financial Officer
TEAMAtlassian Corp
Open-market sale
SELL$17K
204 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

19
DB
Duffy BrianChief Revenue Officer
TEAMAtlassian Corp
Open-market sale
SELL$2,507
30 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

19
DB
Duffy BrianChief Revenue Officer
TEAMAtlassian Corp
Open-market sale
SELL$12K
151 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

19
PE
Phelps ErikEVP, Chief Admin. Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
3,814 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

19
BL
Binz Joseph LeoChief Financial Officer
TEAMAtlassian Corp
Open-market sale
SELL$3,342
40 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

19
DB
Duffy BrianChief Revenue Officer
TEAMAtlassian Corp
Open-market sale
SELL$42K
516 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

19
DB
Duffy BrianChief Revenue Officer
TEAMAtlassian Corp
Open-market sale
SELL$43K
525 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

15
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$300K
45.1K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

13
PA
Polovin AndrewEVP, Chief Legal Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$6,097
100 sh
Feb 20, 2026Feb 20, 2026
traded Feb 20, 2026
+0dSEC Form 4

Evidence

11
SK
Subaiya Thimaya K.EVP, Operations
CSCOCISCO SYSTEMS, INC.
Open-market sale · 10b5-1 plan
SELL$662K
8,433 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

8
SK
Subaiya Thimaya K.EVP, Operations
CSCOCISCO SYSTEMS, INC.
Open-market sale · 10b5-1 plan
SELL$142K
1,800 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

8
MA
Malik AsthaChief Business Officer
BRZEBraze, Inc.
Open-market sale · 10b5-1 plan
SELL$238K
14.0K sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

6
UM
Uychiat Pison MarivicDirector
ENSGENSIGN GROUP, INC
Open-market sale · 10b5-1 plan
SELL$14K
67 sh
Feb 20, 2026Feb 20, 2026
traded Feb 20, 2026
+0dSEC Form 4

Evidence

6
UM
Uychiat Pison MarivicDirector
ENSGENSIGN GROUP, INC
Open-market sale · 10b5-1 plan
SELL$18K
83 sh
Feb 19, 2026Feb 20, 2026
traded Feb 19, 2026
+1dSEC Form 4

Evidence

4
KK
Keough KelliEVP, GBUL, SIPS
SOFISoFi Technologies, Inc.
Open-market sale · 10b5-1 plan
SELL$184K
9,755 sh
Feb 20, 2026Feb 20, 2026
traded Feb 20, 2026
+0dSEC Form 4

Evidence

4
GP
Gravier PierreCHIEF FINANCIAL OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$208K
2,992 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

1
TS
Treadway Anthony SheaSVP, Chief Revenue Officer
TNETTRINET GROUP, INC.
Open-market sale · 10b5-1 plan
SELL$20K
487 sh
Feb 18, 2026Feb 20, 2026
traded Feb 18, 2026
+2dSEC Form 4

Evidence

50
GR
Gabosch Bradley RDirector
ODFLOLD DOMINION FREIGHT LINE, INC.
Open-market sale
SELL$609K
3,134 sh
Feb 18, 2026Feb 19, 2026
traded Feb 18, 2026
+1dSEC Form 4

Evidence

46
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale
SELL$2.26M
18.1K sh
Feb 17, 2026Feb 19, 2026
traded Feb 17, 2026
+2dSEC Form 4

Evidence

46
GS
Gajendra SanjayDirector, President and COO
ALABAstera Labs, Inc.
Open-market sale
SELL$1.16M
9,185 sh
Feb 17, 2026Feb 19, 2026
traded Feb 17, 2026
+2dSEC Form 4

Evidence

46
MJ
Mohan JitendraDirector, Chief Executive Officer
ALABAstera Labs, Inc.
Open-market sale
SELL$3.49M
28.2K sh
Feb 17, 2026Feb 19, 2026
traded Feb 17, 2026
+2dSEC Form 4

Evidence